Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines

Lipoprotein(a) (Lp(a)) is an independent cardiovascular risk factor playing a causal role for atherosclerotic cardiovascular disease (CVD). Lipoprotein apheresis (LA) is a safe well-tolerated outpatient treatment to lower LDL-C and Lp(a) by 60–70%, and is the ultimate escalating therapeutic option i...

Descripción completa

Detalles Bibliográficos
Autores principales: Klingel, Reinhard, Heibges, Andreas, Fassbender, Cordula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352778/
https://www.ncbi.nlm.nih.gov/pubmed/28185214
http://dx.doi.org/10.1007/s11789-017-0082-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352778/
https://www.ncbi.nlm.nih.gov/pubmed/28185214
http://dx.doi.org/10.1007/s11789-017-0082-3

Ejemplares similares